Biopharma Chromatography: Segregating Opportunities of all Sizes

Chromatography systems are essential in a variety of fields, including the biological sciences. Biopharma accounts for almost 30 per cent of this market, making it a key sector for chromatography systems. The main forces behind India's dominant market position would be the enabling government policies and the growing number of foreign research and industrial contracts. Beginning in 2028, India will create a demand for more than 1000 biopharma chromatography systems yearly.

- 

Chromatography systems play a critical role across different industries, in processes like drug development, nutritional analysis, toxin detection, pollutant analysis, among others. This being one of the most preferred methods for the separation and purification of compounds across the aforementioned industries, its market share is worth $10+ billion as of 2025. Approximately 30 per cent of this market is driven by biopharma, making it a cornerstone industry for chromatography systems.

Biopharma Chromatography Market

Ever since the outbreak of COVID-19, the world has been on its toes regarding healthcare operations. Governments and the public have become more alert towards healthcare facilities and 2020 can be seen as a landmark year that reshaped several trends within the healthcare sector, including chromatography.

To tackle COVID-19 at its peak, the year 2020 saw the highest increase (>10 per cent higher compared to 2019) in global healthcare spending and the Biopharma sector saw its highest ever ~130 per cent increase in funding from $58 billion in 2019 to ~$134 billion in 2020. For chromatography systems specifically, the pandemic led to an increased usage of single-use systems (SUS) to avoid crosscontamination and to support the then-necessary rapid vaccine production. As a result, the acceptance of SUSs in different clinical and commercial production processes has increased from an average of ~50 per cent in 2019, to ~70 per cent in 2024.